Your institution may have access to this item. Find your institution then sign in to continue.
Title
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients.
Authors
Brunnberg, U.; Mohr, M.; Noppeney, R.; Dürk, H. A.; Sauerland, M. C.; Müller-Tidow, C.; Krug, U.; Koschmieder, S.; Kessler, T.; Mesters, R. M.; Schulz, C.; Kosch, M.; Büchner, T.; Ehninger, G.; Dührsen, U.; Serve, H.; Berdel, W. E.